CONNECT WITH US
HealthTech

HealthTech

Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood

Medical Xpress logo

Published on

Add as a preferred source on Google
Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that could advance cancer treatment and vaccine design.

mRNA-lipid nanoparticles (LNPs) transformed the way that vaccines are delivered to humans when they became widely used during the COVID-19 pandemic.

mRNA-LNPs are tiny parcels, ~800 times smaller than the width of a human hair, made of fatty acids (lipids) and containing cargo (messenger RNA) that needs to be delivered inside the body to generate a treatment response (for example, immunity to a virus).

Today, researchers around the world are investigating mRNA-LNPs as candidates for "cancer vaccines" that would deliver mRNA cargo to boost the patient's immune system and empower it to kill cancer more effectively.

Led by researchers at the Olivia Newton-John Cancer Research Institute (ONJCRI) and the Peter Doherty Institute for Infection and Immunity, this study analyzed 327 blood samples from 73 participants who received Moderna, Pfizer or an investigational COVID-19 mRNA vaccine.

The team assessed whether the mRNA cargo was present in the blood and remained intact after delivery, the stability of the lipid-based packaging and where degradation occurred in the mRNA cargo.

Dr. Yi (David) Ju, senior author of the paper published in ACS Nano and laboratory head at ONJCRI, affiliated with La Trobe University as the School of Cancer Medicine, said, "mRNA vaccines do not all behave the same way in the bloodstream.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.